Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Lancet. Oncology|February 5, 2010
Use of new imaging techniques to predict tumour response to therapyVanessa N Harry, Scott I Semple, David E Parkin, et al.Gynecologic Oncology|September 9, 2008
Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancerVanessa N Harry, Scott I Semple, Fiona J Gilbert, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 28, 2009
Magnetic resonance imaging in gynecological oncologyVanessa N Harry, Heather Deans, Emma Ramage, et al.International Journal of Radiation Oncology, Biology, Physics|September 9, 2009
A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancerScott I K Semple, Vanessa N Harry, David E Parkin, et al.Obstetrics and Gynecology|August 2, 2007
Isolated clear cell adenocarcinoma in scar endometriosis mimicking an incisional herniaVanessa N Harry, Smruta Shanbhag, Matthew Lyall, et al.Anticancer Research|January 29, 2018
Surgical Outcomes and Morbidity After Radical Surgery for Ovarian Cancer in Aberdeen Royal Infirmary, the Northeast of Scotland Gynaecologic Oncology CentreEmmanouil Kalampokas, Helena Young, Antonina Bednarek, et al.European Journal of Cancer Care|January 17, 2020
Definitive chemoradiotherapy for cervical cancer: A 11-year population-based studyEmmanouil Kalampokas, Graham Macdonald, Helena Young, et al.Cancers|September 23, 2022
Current Approaches to the Management of Patients with Endometrial CancerEmmanouil Kalampokas, Georgios Giannis, Theodoros Kalampokas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markersDiane Downie, Morag C E McFadyen, Patrick H Rooney, et al.European Journal of Cancer (Oxford, England : 1990)|April 17, 2010
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC seriesRoshan Agarwal, Charlie Gourley, Timothy J Perren, et al.Pageof 2